Insider Trading activities at Sangamo Therapeutics, Inc (SGMO) , Part 2

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sangamo Therapeutics, Inc (SGMO) since 2013 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Sangamo Therapeutics, Inc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1001233.

Total stock buying since 2013: $48,557,988.
Total stock sales since 2013: $122,803,894.
Total stock option exercises since 2013: $5,403,803.


 1   2 
23 insiders reported insider trading activities at Sangamo Therapeutics, Inc (SGMO):
Insider trading activities of Markels John
Insider trading activities of Loeb Gary
Insider trading activities of Mento Steven J
Insider trading activities of Gregory Philip D
Insider trading activities of Wolff Henry Ward
Insider trading activities of Dilly Stephen George
Insider trading activities of Zakrzewski Joseph S
Insider trading activities of Dubois-stringfellow Nathalie
Insider trading activities of Conner Edward R.
Insider trading activities of Ringo William R
Insider trading activities of Herberts Curt A. Iii
Insider trading activities of Davis Gregory D
Insider trading activities of Ramasastry Saira
Insider trading activities of Parker H Stewart
Insider trading activities of Yi Kathy
Insider trading activities of Jeffs Roger
Insider trading activities of Kolchinsky Peter
Insider trading activities of Ando Dale G
Insider trading activities of Biogen Ma Inc.
Insider trading activities of Larson John William
Insider trading activities of Lanphier Edward O Ii
Insider trading activities of Boissel Stephane
Insider trading activities of Ramelmeier Rolf Andrew

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Sangamo Therapeutics, Inc (SGMO).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2026 0 $0 415,769 $106,919 0 $0
2023 0 $0 6,000,000 $3,000,000 0 $0
2022 21,784 $79,011 500,000 $2,657,300 0 $0
2021 0 $0 285,215 $2,526,092 11,981 $132,030
2020 28,000 $163,535 65,795 $534,643 74,907 $330,900
2019 0 $0 30,000 $327,379 41,137 $129,750
2018 11,408 $145,531 203,059 $3,698,265 208,908 $1,189,896
2017 0 $0 130,546 $1,840,392 104,395 $730,815
2015 0 $0 504,501 $7,183,477 494,000 $2,890,412
2014 2,771,198 $47,805,024 5,925,256 $92,908,653 0 $0
2013 33,840 $364,887 817,444 $8,020,774 0 $0


Table 3. Detailed insider trading at Sangamo Therapeutics, Inc (SGMO) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2015-06-01 Gregory Philip D (SVP of Research & CSO) Sale 15,000 12.39 185,820
2015-06-01 Gregory Philip D (SVP of Research & CSO) Option Ex 15,000 4.83 72,495
2015-05-15 Lanphier Edward O Ii (President & CEO) Sale 25,000 11.52 287,875
2015-05-15 Lanphier Edward O Ii (President & CEO) Option Ex 25,000 6.82 170,500
2015-05-11 Wolff Henry Ward (Exec VP & CFO) Sale 12,000 13.25 158,952
2015-05-11 Wolff Henry Ward (Exec VP & CFO) Option Ex 10,000 3.45 34,500
2015-05-05 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 15,000 12.29 184,305
2015-05-05 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 15,000 3.45 51,750
2015-05-04 Ringo William R Sale 3,000 12.98 38,928
2015-05-04 Ringo William R Option Ex 3,000 6.23 18,690
2015-05-01 Gregory Philip D (SVP of Research & CSO) Sale 15,000 12.62 189,375
2015-05-01 Gregory Philip D (SVP of Research & CSO) Option Ex 15,000 4.83 72,495
2015-04-15 Lanphier Edward O Ii (President & CEO) Sale 25,000 15.33 383,250
2015-04-15 Lanphier Edward O Ii (President & CEO) Option Ex 25,000 6.82 170,500
2015-04-10 Wolff Henry Ward (Exec VP & CFO) Sale 12,000 15.37 184,380
2015-04-10 Wolff Henry Ward (Exec VP & CFO) Option Ex 10,000 3.45 34,500
2015-04-06 Ringo William R Sale 2,200 14.95 32,881
2015-04-06 Ringo William R Option Ex 2,200 6.41 14,102
2015-04-06 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 15,000 14.95 224,175
2015-04-06 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 15,000 3.45 51,750
2015-04-01 Gregory Philip D (SVP of Research & CSO) Sale 15,000 15.15 227,190
2015-04-01 Gregory Philip D (SVP of Research & CSO) Option Ex 15,000 4.83 72,495
2015-03-19 Wolff Henry Ward (Exec VP & CFO) Sale 10,000 18.00 180,000
2015-03-19 Wolff Henry Ward (Exec VP & CFO) Option Ex 10,000 14.27 142,700
2015-03-16 Lanphier Edward O Ii (President & CEO) Sale 25,000 17.29 432,300
2015-03-16 Lanphier Edward O Ii (President & CEO) Option Ex 25,000 6.82 170,500
2015-03-10 Wolff Henry Ward (Exec VP & CFO) Sale 12,000 16.68 200,196
2015-03-10 Wolff Henry Ward (Exec VP & CFO) Option Ex 10,000 3.45 34,500
2015-03-05 Mento Steven J Sale 6,501 18.30 118,942
2015-03-05 Mento Steven J Option Ex 10,000 4.54 45,400
2015-03-05 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 15,000 18.29 274,290
2015-03-05 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 15,000 3.45 51,750
2015-03-04 Wolff Henry Ward (Exec VP & CFO) Sale 10,000 18.00 180,000
2015-03-04 Wolff Henry Ward (Exec VP & CFO) Option Ex 10,000 14.27 142,700
2015-03-03 Ringo William R Sale 2,200 17.21 37,862
2015-03-03 Ringo William R Option Ex 2,200 6.41 14,102
2015-03-02 Gregory Philip D (SVP of Research & CSO) Sale 15,000 17.26 258,945
2015-03-02 Gregory Philip D (SVP of Research & CSO) Option Ex 15,000 7.12 106,800
2015-02-17 Lanphier Edward O Ii (President & CEO) Sale 25,000 15.69 392,150
2015-02-17 Lanphier Edward O Ii (President & CEO) Option Ex 25,000 6.82 170,500
2015-02-12 Ramasastry Saira Sale 10,000 15.00 150,000
2015-02-12 Ramasastry Saira Option Ex 10,000 5.03 50,300
2015-02-10 Wolff Henry Ward (Exec VP & CFO) Sale 12,000 12.64 151,692
2015-02-10 Wolff Henry Ward (Exec VP & CFO) Option Ex 10,000 3.45 34,500
2015-02-05 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 15,000 12.93 193,950
2015-02-05 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 15,000 5.13 77,025
2015-02-03 Ringo William R Sale 2,200 12.70 27,940
2015-02-03 Ringo William R Option Ex 2,200 6.41 14,102
2015-02-02 Gregory Philip D (SVP of Research & CSO) Sale 15,000 12.86 192,825
2015-02-02 Gregory Philip D (SVP of Research & CSO) Option Ex 15,000 4.83 72,495
2015-01-16 Lanphier Edward O Ii (President & CEO) Sale 10,000 14.29 142,850
2015-01-16 Lanphier Edward O Ii (President & CEO) Option Ex 10,000 6.82 68,200
2015-01-15 Lanphier Edward O Ii (President & CEO) Sale 15,000 14.53 217,935
2015-01-15 Lanphier Edward O Ii (President & CEO) Option Ex 15,000 6.82 102,300
2015-01-12 Wolff Henry Ward (Exec VP & CFO) Sale 12,000 15.87 190,452
2015-01-12 Wolff Henry Ward (Exec VP & CFO) Option Ex 10,000 3.45 34,500
2015-01-05 Ringo William R Sale 2,200 15.20 33,429
2015-01-05 Ringo William R Option Ex 2,200 6.41 14,102
2015-01-05 Larson John William Sale 15,000 15.10 226,545
2015-01-05 Larson John William Option Ex 15,000 6.40 96,000
2015-01-05 Ando Dale G (VP, Therapeutic Dev. & CMO) Sale 15,000 15.41 231,210
2015-01-05 Ando Dale G (VP, Therapeutic Dev. & CMO) Option Ex 15,000 6.82 102,300
2015-01-02 Gregory Philip D (SVP, Research & CSO) Sale 15,000 15.78 236,670
2015-01-02 Gregory Philip D (SVP, Research & CSO) Option Ex 15,000 7.12 106,800
2014-08-01 Kolchinsky Peter Sale 27,770 12.82 356,094
2014-07-30 Kolchinsky Peter Sale 109,590 12.44 1,362,751
2014-07-29 Kolchinsky Peter Sale 1,407 12.41 17,463
2014-07-28 Kolchinsky Peter Sale 60,081 12.11 727,400
2014-07-25 Kolchinsky Peter Sale 47,429 12.31 583,945
2014-07-24 Kolchinsky Peter Sale 124,050 12.28 1,523,209
2014-07-17 Kolchinsky Peter Buy 37,215 12.26 456,218
2014-07-01 Kolchinsky Peter Sale 82,700 16.00 1,323,282
2014-06-16 Kolchinsky Peter Sale 250,500 16.50 4,132,999
2014-06-09 Kolchinsky Peter Sale 83,500 15.50 1,294,166
2014-06-06 Kolchinsky Peter Sale 135,101 14.20 1,918,569
2014-06-05 Kolchinsky Peter Sale 1,085,463 13.84 14,779,008
2014-06-04 Kolchinsky Peter Sale 70,640 13.10 925,172
2014-06-03 Kolchinsky Peter Sale 76,833 12.86 988,072
2014-05-30 Kolchinsky Peter Sale 65,884 13.41 883,702
2014-05-29 Kolchinsky Peter Sale 155,675 13.52 2,105,193
2014-05-28 Kolchinsky Peter Sale 148,689 13.45 1,999,569
2014-05-27 Kolchinsky Peter Sale 263,437 13.55 3,570,625
2014-05-23 Kolchinsky Peter Sale 51,597 13.27 684,692
2014-05-22 Kolchinsky Peter Sale 56,396 13.54 763,714
2014-05-13 Kolchinsky Peter Sale 56,060 13.12 735,282
2014-05-12 Kolchinsky Peter Sale 29,659 13.03 386,545
2014-05-08 Kolchinsky Peter Sale 83,300 12.39 1,032,420
2014-05-07 Kolchinsky Peter Buy 83,300 11.90 989,461
2014-04-30 Kolchinsky Peter Buy 124,500 13.43 1,671,537
2014-04-28 Kolchinsky Peter Buy 74,844 13.29 995,050
2014-04-25 Kolchinsky Peter Buy 166,000 13.63 2,262,746
2014-04-22 Kolchinsky Peter Sale 352,750 14.86 5,243,276
2014-04-17 Kolchinsky Peter Buy 41,500 14.02 581,954
2014-04-16 Kolchinsky Peter Sale 21,829 14.09 307,657
2014-04-15 Kolchinsky Peter Buy 21,829 13.13 286,614
2014-04-14 Kolchinsky Peter Sale 3,055 14.78 45,165
2014-04-11 Kolchinsky Peter Buy 116,992 14.48 1,694,512
2014-04-10 Kolchinsky Peter Buy 83,000 14.91 1,237,364
2014-04-10 Kolchinsky Peter Sale 3,403 15.67 53,325
2014-04-09 Kolchinsky Peter Sale 69,856 16.27 1,136,417
2014-04-08 Kolchinsky Peter Buy 121,876 15.49 1,888,224
2014-04-07 Kolchinsky Peter Buy 33,667 15.43 519,313
2014-04-04 Kolchinsky Peter Buy 179,031 15.38 2,753,675
2014-04-03 Kolchinsky Peter Buy 195,126 16.61 3,242,018
2014-04-01 Kolchinsky Peter Sale 250,000 17.98 4,495,750
2014-03-28 Kolchinsky Peter Buy 84,000 17.09 1,435,392
2014-03-27 Kolchinsky Peter Buy 256,187 17.50 4,484,297
2014-03-26 Kolchinsky Peter Buy 210,013 18.02 3,784,224
2014-03-25 Kolchinsky Peter Buy 84,000 19.41 1,630,356
2014-03-21 Kolchinsky Peter Buy 101,808 21.22 2,159,958
2014-03-19 Kolchinsky Peter Sale 17,808 24.28 432,431
2014-03-18 Kolchinsky Peter Sale 84,000 23.75 1,994,580
2014-03-17 Kolchinsky Peter Buy 52,161 23.02 1,200,850
2014-03-13 Kolchinsky Peter Buy 71,319 22.76 1,623,363
2014-03-12 Kolchinsky Peter Sale 123,480 23.40 2,889,432
2014-03-10 Kolchinsky Peter Buy 12,522 22.30 279,177
2014-03-07 Kolchinsky Peter Buy 258,377 22.25 5,748,629
2014-03-06 Kolchinsky Peter Buy 84,001 22.50 1,890,274
2014-03-06 Kolchinsky Peter Sale 354,900 23.79 8,368,700
2014-03-03 Kolchinsky Peter Sale 84,000 18.22 1,530,312
2014-02-28 Kolchinsky Peter Buy 42,000 18.10 760,158
2014-02-27 Kolchinsky Peter Sale 32,196 19.36 623,282
2014-02-26 Kolchinsky Peter Buy 74,194 19.52 1,448,563
2014-02-20 Kolchinsky Peter Sale 35,319 18.39 649,693
2014-02-19 Kolchinsky Peter Sale 6,720 18.52 124,420
2014-02-18 Kolchinsky Peter Sale 11,172 18.11 202,280
2014-02-14 Kolchinsky Peter Sale 15,380 18.61 286,160
2014-02-13 Kolchinsky Peter Sale 15,409 18.46 284,434
2014-02-12 Kolchinsky Peter Buy 42,000 18.04 757,638
2014-02-11 Kolchinsky Peter Buy 42,000 19.65 825,258
2014-02-07 Kolchinsky Peter Sale 34,688 18.52 642,421
2014-02-06 Kolchinsky Peter Sale 7,312 18.42 134,679
2014-02-05 Kolchinsky Peter Buy 42,000 18.25 766,332
2014-01-09 Kolchinsky Peter Sale 72,440 18.37 1,331,012
2013-12-13 Kolchinsky Peter Buy 5,040 12.09 60,923
2013-12-12 Kolchinsky Peter Buy 9,600 12.09 116,073
2013-07-25 Kolchinsky Peter Sale 368,870 9.78 3,609,024
2013-07-23 Kolchinsky Peter Sale 5,012 9.37 46,937
2013-07-22 Kolchinsky Peter Sale 111,363 9.57 1,066,300
2013-07-19 Kolchinsky Peter Sale 209,894 9.83 2,063,467
2013-07-18 Kolchinsky Peter Sale 74,035 10.02 741,534
2013-07-17 Kolchinsky Peter Buy 19,200 9.79 187,891
2013-07-17 Kolchinsky Peter Sale 48,270 10.22 493,512
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of SGMO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Sangamo Therapeutics, Inc (symbol SGMO, CIK number 1001233) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.